UT Health Science Center researchers Gabor Tigyi, MD, PhD, Harriet Van Vleet Endowment Professor in Basic Oncology Research, Junming Yue, PhD, associate professor in the Department of Pathology, Sue Chin Lee, PhD, in the Department of Physiology, and David Schwartz, MD, chair of the Department of Radiation Oncology, are part of a scientific leadership group awarded $20 million from the University of Tennessee-Oak Ridge Innovation Institute in partnership with Oak Ridge National Laboratory and the University of Tennessee, Knoxville, to develop new radiopharmaceutical therapies to treat cancer.

Related Keywords

University Of Tennessee , Tennessee , United States , Oak Ridge , Tennesseans , David Schwartz , Sandra Davern , Chin Lee , Stephen Streiffer , Peter Buckley , Deborah Crawford , Junming Yue , Rachel Patton Mccord , Gabor Tigyi , Susan Hubbard , Randy Boyd , David Sholl , Wesley Byerly , Steve Goodman , Department Of Radiation Oncology , Radiotherapeutics Through Advanced Molecular Constructs Initiative , Department Of Physiology , Development Initiative , Convergent Research Initiatives Cris , Tennessee Department Of Health , University Of Tennessee Health Science Center , Ut Health Science Center , Applications Initiative , Economic Development , Oak Ridge Innovation Institute , Schwartz , Department Of Pathology , Buckley , Health Equity , Convergent Research , Oak Ridge National Laboratory , Department Of Defense , Tennessee Health Science , Science Center , Harriet Van Vleet Endowment Professor , Basic Oncology Research , Sue Chin Lee , Radiation Oncology , Tennessee Oak Ridge Innovation Institute , Drug Discovery , Martha Head , Convergent Research Initiatives , Oak Ridge National , Tennessee Department , Director Stephen Streiffer , Deputy Director Susan Hubbard , Executive Director David Sholl , Vice Chancellor , Cancer , Laboratory , Ncology , Pathology , Hysiology , Research ,